Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry of acquisitions at a similar price point. Source link

Continue ReadingNovartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

‘Frenzied as ever’ — the Dan Ives-led Worldcoin treasury purchase is only latest example of market madness

The 3,000% surge in Eightco Holdings on the purchase of a digital asset that can be acquired independently is just the latest example of what one analyst calls “market madness.”…

Continue Reading‘Frenzied as ever’ — the Dan Ives-led Worldcoin treasury purchase is only latest example of market madness

Fed is almost certain to cut rates by 25 basis points after months of debate. Why are so many people unhappy with that?

Economists are split into opposite camps on which is more important for the Fed to battle — slower growth or higher inflation. Source link

Continue ReadingFed is almost certain to cut rates by 25 basis points after months of debate. Why are so many people unhappy with that?

Stock market’s consumer sectors are ‘unfavorable’ after lagging S&P 500 earnings growth

The U.S. stock market’s consumer sectors remain “unfavorable” amid ongoing concern over how tariffs may change shopping behavior, according to the Wells Fargo Investment Institute. Source link

Continue ReadingStock market’s consumer sectors are ‘unfavorable’ after lagging S&P 500 earnings growth